Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for eye gaze during speech in adults who stutter
ACTRN12611000434998Phase 2Not yet recruiting
- Sponsor
- University of Sydney
- Start
- May 2011
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised trial in childhood-onset fluency disorder (COFD) comparing Intranasal oxytocin with Placebo nasal spray (2 arms). Primary endpoint: Eye gaze toward audience members. Planned start May 2011; status: not yet recruiting.
02
Drugs
oxytocin
03
Conditions
childhood-onset fluency disorder (COFD)
Beyond the preview
Go deeper on ACTRN12611000434998.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12611000434998.